Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ames

Showing results (301-310 of 416) with videos related to

Pageof 42
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 1, 2019
Conformational Dynamics Underlies Different Functions of Human KDM7 Histone DemethylasesShobhit S Chaturvedi, Rajeev Ramanan, Sodiq O Waheed, et al.
The Ocular Surface|March 26, 2021
Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologiesLulia Koujah, Mowafak Allaham, Chandrashekhar D Patil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancerGrzegorz S Nowakowski, Andrea K McCollum, Matthew M Ames, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2002
Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942Robert J Wells, Joel M Reid, Matthew M Ames, et al.
Molecular & Cellular Proteomics : MCP|September 21, 2004
Proteomic analysis of arginine adducts on glyoxal-modified ribonucleaseWilliam E Cotham, Thomas O Metz, P Lee Ferguson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
The metabolism of pyrazoloacridine (NSC 366140) by cytochromes p450 and flavin monooxygenase in human liver microsomesJoel M Reid, Denise L Walker, Jennifer K Miller, et al.
Annals of Neurology|May 31, 2017
Differential neuronal susceptibility and apoptosis in congenital Zika virus infectionCheng-Ying Ho, Heather M Ames, Ashley Tipton, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2010
Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in ratsJoel M Reid, Sarah A Buhrow, Mary J Kuffel, et al.
Journal of Clinical Pharmacology|February 26, 2013
Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjectsAlexander K Berg, Sumithra J Mandrekar, Katie L Allen Ziegler, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 21, 2012
Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agentsDavid E Zembower, Yongping Xie, Ali Koohang, et al.
Pageof 42

Showing results (301-310 of 416) with videos related to

Sort By:
Pageof 42
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 1, 2019
Conformational Dynamics Underlies Different Functions of Human KDM7 Histone DemethylasesShobhit S Chaturvedi, Rajeev Ramanan, Sodiq O Waheed, et al.
The Ocular Surface|March 26, 2021
Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologiesLulia Koujah, Mowafak Allaham, Chandrashekhar D Patil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancerGrzegorz S Nowakowski, Andrea K McCollum, Matthew M Ames, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2002
Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942Robert J Wells, Joel M Reid, Matthew M Ames, et al.
Molecular & Cellular Proteomics : MCP|September 21, 2004
Proteomic analysis of arginine adducts on glyoxal-modified ribonucleaseWilliam E Cotham, Thomas O Metz, P Lee Ferguson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
The metabolism of pyrazoloacridine (NSC 366140) by cytochromes p450 and flavin monooxygenase in human liver microsomesJoel M Reid, Denise L Walker, Jennifer K Miller, et al.
Annals of Neurology|May 31, 2017
Differential neuronal susceptibility and apoptosis in congenital Zika virus infectionCheng-Ying Ho, Heather M Ames, Ashley Tipton, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2010
Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in ratsJoel M Reid, Sarah A Buhrow, Mary J Kuffel, et al.
Journal of Clinical Pharmacology|February 26, 2013
Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjectsAlexander K Berg, Sumithra J Mandrekar, Katie L Allen Ziegler, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 21, 2012
Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agentsDavid E Zembower, Yongping Xie, Ali Koohang, et al.
Pageof 42